Heterodimeric antibodies that bind CD3 and tumor antigens Grant US-11945880-B2 United States of America 02 Apr 2024
Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3 Grant US-11919956-B2 United States of America 05 Mar 2024
Heterodimeric antibodies that bind CD3 and GPC3 Grant US-11859012-B2 United States of America 02 Jan 2024
Heterodimeric antibodies that bind CD3 and tumor antigens Grant US-11859011-B2 United States of America 02 Jan 2024
Bispecific antibodies that bind to CD38 and CD3 Grant US-11840579-B2 United States of America 12 Dec 2023
Heterodimeric antibodies that bind CD3 and CLDN6 Grant US-11739144-B2 United States of America 29 Aug 2023
Heterodimeric antibodies that bind CD3 and tumor antigens Grant US-11673972-B2 United States of America 13 Jun 2023
Heterodimeric antibodies that bind CD3 and PSMA Grant US-11623957-B2 United States of America 11 Apr 2023
PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins… Grant US-11524991-B2 United States of America 13 Dec 2022
TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins… Grant US-11505595-B2 United States of America 22 Nov 2022
Heterodimeric antibodies that bind ENPP3 and CD3 Grant US-11472890-B2 United States of America 18 Oct 2022
Heterodimeric antibodies that bind CD3 and CD38 Grant US-11352442-B2 United States of America 07 Jun 2022
Bispecific and monospecific antibodies using novel anti-PD-1 sequences Grant US-11312770-B2 United States of America 26 Apr 2022
Heterodimeric antibodies that bind somatostatin receptor 2 Grant US-11225521-B2 United States of America 18 Jan 2022
Heterodimeric antibodies that bind CD3 and tumor antigens Grant US-11225528-B2 United States of America 18 Jan 2022
Heterodimeric antibodies that bind CD3 and tumor antigens Grant US-11111315-B2 United States of America 07 Sep 2021
Modulation of T cells with bispecific antibodies and Fc fusions Grant US-11091548-B2 United States of America 17 Aug 2021
Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding… Grant US-11084863-B2 United States of America 10 Aug 2021
Heterodimeric antibodies that bind fibroblast activation protein Grant US-10982006-B2 United States of America 20 Apr 2021
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors Grant US-10981992-B2 United States of America 20 Apr 2021
Heterodimeric antibodies that bind CD3 and tumor antigens Grant US-10913803-B2 United States of America 09 Feb 2021
Heterodimeric antibodies that bind CD3 and tumor antigens Grant US-10889653-B2 United States of America 12 Jan 2021
Heterodimeric human IgG1 polypeptides with isoelectric point modifications Grant US-10851178-B2 United States of America 01 Dec 2020
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors Grant US-10793632-B2 United States of America 06 Oct 2020
Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and… Grant US-10550185-B2 United States of America 04 Feb 2020
Targeting regulatory T cells with heterodimeric proteins Grant US-10544187-B2 United States of America 28 Jan 2020
Targeting regulatory T cells with heterodimeric proteins Grant US-10519242-B2 United States of America 31 Dec 2019
IL15/IL15Rα heterodimeric Fc-fusion proteins Grant US-10501543-B2 United States of America 10 Dec 2019
Heterodimeric antibodies that bind CD3 and tumor antigens Grant US-10259887-B2 United States of America 16 Apr 2019
Heterodimeric antibodies that bind CD3 and PSMA Grant US-10227410-B2 United States of America 12 Mar 2019
Modulation of T cells with bispecific antibodies and FC fusions Grant US-10227411-B2 United States of America 12 Mar 2019